[HTML][HTML] Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis

S Zhou, X Liu, X Wang, F Xi, X Luo, L Yao, H Tang - Medicine, 2019 - journals.lww.com
Background: The global prevalence of Irritable bowel syndrome (IBS) is estimated to be as
high as 15% and a number of different non-pharmacological and pharmacological …

[HTML][HTML] Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis

S Zhou, X Liu, X Wang, F Xi, X Luo, L Yao, H Tang - Medicine, 2019 - ncbi.nlm.nih.gov
Background: The global prevalence of Irritable bowel syndrome (IBS) is estimated to be as
high as 15% and a number of different non-pharmacological and pharmacological …

Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis

S Zhou, X Liu, X Wang, F Xi, X Luo, L Yao… - Medicine, 2019 - pubmed.ncbi.nlm.nih.gov
Background The global prevalence of Irritable bowel syndrome (IBS) is estimated to be as
high as 15% and a number of different non-pharmacological and pharmacological …

Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.

S Zhou, X Liu, X Wang, F Xi, X Luo, L Yao, H Tang - Medicine, 2019 - europepmc.org
Background The global prevalence of Irritable bowel syndrome (IBS) is estimated to be as
high as 15% and a number of different non-pharmacological and pharmacological …

Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.

S Zhou, X Liu, X Wang, F Xi, X Luo, L Yao, H Tang - Medicine, 2019 - europepmc.org
Background The global prevalence of Irritable bowel syndrome (IBS) is estimated to be as
high as 15% and a number of different non-pharmacological and pharmacological …